Healthcare Services Industry Report
Market Cap: $214.1B
Stocks: 57
Median P/E: 11.6x
Median ROIC: 1.0%
Data sourced from SEC EDGAR filings. Report refreshed weekly.
Part of the Healthcare sector.
Performance Dashboard
| Period | Sector (MCW) | Sector (Median) |
|---|---|---|
| 1 Day | +0.6% | +0.0% |
| 1 Week | +0.6% | -0.2% |
| 1 Month | — | — |
| 3 Months | — | — |
| 6 Months | — | — |
| YTD | +1.9% | +0.4% |
| 1 Year | +36.5% | +8.6% |
| 3 Years | +106.5% | +2.5% |
| 5 Years | +40.4% | -56.0% |
Today's Breadth: 28 advancing · 18 declining · 10 flat
Valuation Summary
| Metric | Median | P25 | P75 | vs 5Y Avg |
|---|---|---|---|---|
| P/E | 11.6x | 0.0x | 24.2x | -27% |
| P/B | 2.6x | 0.7x | 4.5x | -9% |
| P/S | 0.9x | 0.2x | 2.0x | — |
| P/FCF | 16.5x | 6.6x | 28.8x | — |
| EV/EBITDA | 13.8x | 8.6x | 24.3x | — |
| EV/EBIT | 17.8x | 13.1x | 39.4x | — |
Earnings Yield
4.2%
FCF Yield
2.9%
Below Fair Value
38% of stocks
Profitability Profile
Margins
| Metric | Median | 5Y Avg | P25 | P75 |
|---|---|---|---|---|
| Gross Margin | 47.0% | 38.7% | 27.8% | 64.6% |
| Operating Margin | 2.5% | — | -9.2% | 9.5% |
| Net Margin | -2.3% | -4.2% | -10.3% | 5.6% |
| FCF Margin | 6.5% | — | -1.0% | 9.6% |
Returns on Capital
| Metric | Median | 5Y Avg | P25 | P75 |
|---|---|---|---|---|
| ROE | -1.4% | — | -15.6% | 10.7% |
| ROA | -3.9% | — | -24.7% | 4.4% |
| ROIC | 1.0% | -1.7% | -16.1% | 8.9% |
Growth Metrics
| Metric | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|
| Revenue | +10.4% | +7.8% | +13.2% |
| EPS | +23.8% | +15.7% | -2.4% |
| Free Cash Flow | +16.5% | +10.0% | -1.5% |
All values represent sector median growth rates.
Balance Sheet Health
Debt / Equity
0.7x
Net Debt / EBITDA
2.6x
Interest Coverage
0.5x
Current Ratio
1.6x
Altman Z-Score
Safe (>3): 19 (37%)
Gray (1.8–3): 5 (10%)
Distress (<1.8): 27 (53%)
Piotroski F-Score
Strong (7–9): 13 (23%)
Moderate (4–6): 30 (54%)
Weak (0–3): 13 (23%)
Top Companies
| Symbol | #▲ | Mkt Cap | P/E | EV/EBITDA | ROIC | Net Mgn | Rev Gr. | Div Yld | YTD | Qual. |
|---|---|---|---|---|---|---|---|---|---|---|
| NTRA | 1 | $27.6B | — | — | -13.1% | -9.0% | +35.9% | — | +4.2% | 1/9 |
| LH | 2 | $22.1B | 24.2x | 12.5x | 6.5% | 6.3% | +7.3% | 1.1% | +2.9% | 3/9 |
| DGX | 3 | $21.9B | 20.0x | 11.8x | 9.2% | 9.0% | +11.8% | 1.8% | -1.1% | 3/9 |
| EXAS | 4 | $19.8B | — | — | -4.4% | -6.4% | +17.7% | — | 0.0% | 3/9 |
| FMS | 5 | $13.2B | — | — | 7.0% | 6.1% | +6.4% | — | +1.1% | 1/9 |
| FMCQF | 6 | $12.4B | — | — | 7.0% | 6.1% | +6.4% | — | 0.0% | 1/9 |
| DVA | 7 | $11.5B | 11.6x | 6.6x | 15.5% | 5.5% | +6.5% | — | -2.0% | 4/9 |
| GH | 8 | $10.3B | — | — | -34.6% | -42.4% | +32.9% | — | +5.6% | 0/9 |
| BTSG | 9 | $10.1B | 43.4x | 15.2x | 5.2% | 1.5% | +28.2% | — | +12.4% | 0/9 |
| AGL | 10 | $8.6B | — | — | -120.7% | -6.6% | -2.1% | — | +1.5% | 0/9 |
| CHE | 11 | $5.6B | 23.5x | — | 25.4% | 10.5% | +4.1% | 0.5% | -4.6% | 5/9 |
| HIMS | 12 | $5.3B | 67.3x | 56.4x | 16.8% | 5.5% | +59.0% | — | +0.8% | 2/9 |
| OPCH | 13 | $4.7B | 25.6x | 14.9x | 11.1% | 3.7% | +13.0% | — | +1.6% | 5/9 |
| SHC | 14 | $4.5B | 65.6x | 26.5x | 3.9% | 6.7% | +5.7% | — | +2.5% | 2/9 |
| RDNT | 15 | $4.2B | — | 23.5x | 2.2% | -0.9% | +11.5% | — | -0.2% | 0/9 |
| CAI | 16 | $3.2B | — | — | 6.1% | -66.3% | +97.0% | — | — | 2/9 |
| BKD | 17 | $3.2B | — | 17.3x | 0.3% | -8.2% | +2.2% | — | +4.7% | 0/9 |
| CON | 18 | $2.8B | 15.4x | 2.1x | 12.9% | 7.6% | +13.8% | 1.3% | +1.9% | 3/9 |
| VCYT | 19 | $2.6B | 51.8x | — | 6.9% | 12.8% | +16.0% | — | +3.6% | 3/9 |
| ACHC | 20 | $2.4B | — | 53.0x | -23.5% | -33.3% | +5.0% | — | -1.4% | 2/9 |
Industry Composition
| Industry | Stocks | Market Cap | % | |
|---|---|---|---|---|
| Services-Medical Laboratories | 21 | $117.5B | 54.9% | |
| Services-Misc Health & Allied Services, Nec | 12 | $52.2B | 24.4% | |
| Services-Home Health Care Services | 7 | $25.7B | 12.0% | |
| Services-Offices & Clinics Of Doctors Of Medicine | 10 | $8.2B | 3.8% | |
| Services-Specialty Outpatient Facilities, Nec | 4 | $5.3B | 2.5% | |
| Services-Nursing & Personal Care Facilities | 3 | $5.1B | 2.4% |
Quality Distribution
0
1
2
3
4
5
6
7
8
9
Quality Score (0-9)
High Quality (7+)
2%
Median Piotroski F
5/9
Profitable Years
2 of 10
Dividends & Shareholder Returns
Paying Dividends
19%
Median Div Yield
1.3%
Median Buyback Yield
0.5%
Shareholder Yield
1.0%
Payout Ratio
35.5%
Div Growth (3Y)
14.1%
Div Growth (5Y)
3.9%
Strengths & Weaknesses
Strengths
- +[Growth]Strong secular growth with a median 5-year revenue CAGR of 13.2%, outpacing nominal GDP.
- +[Valuation]Attractive valuations: current median P/E of 11.6x is 27.4% below the 5-year average, presenting potential value opportunity.
Weaknesses
- −[Financial Health]52.9% of companies fall in the Altman Z-Score distress zone (<1.8), indicating elevated bankruptcy risk within the sector.
- −[Leverage]Tight interest coverage at 0.5x, leaving limited cushion for debt servicing if earnings decline.
- −[Profitability]Below-average capital returns with a median ROIC of 1.0%, suggesting limited pricing power or capital-intensive operations.
- −[Quality]Only 1.8% of companies score 7+ on the quality checklist, reflecting structural challenges in achieving consistent returns across the sector.